About EmerStat
EmerStat is a Healthcare company based in Singapore (Singapore) founded in 2022 by Vishnu Sunil and Apoorva Katragadda. It creates innovative hemostatic devices for efficient trauma care and surgical applications. It operates on a B2B model. Its chief executive is Vishnu Sunil. EmerStat offers products and services including Hemostatic Device. Its focus areas include Medical Devices, Trauma Care, Hemostatic Solutions and Surgical Equipment. Its competitors include Inari Medical, Akura Medical, Endovascular Engineering, Magneto Thrombectomy and Retriever Medical and 1 more; 4 of its 6 listed competitors have raised funding.
Company details
EmerStat focuses on developing a first-ever non-adherent, drug-free hemostatic device that addresses bleeding management in pre-hospital and surgical environments. This superhydrophobic solution works by minimizing blood loss, accelerating clotting, and enabling easy removal to enhance overall trauma care. The company engages in research and commercialization of medical innovations, targeting healthcare professionals for improved efficiency and effectiveness, though specific locations and clients are not detailed.
- Headquarters Singapore, Singapore
- Founders Vishnu Sunil, Apoorva Katragadda
- SectorsHealthcare
- Email••••••••
- Website emerstat.com
Products & Services of EmerStat
EmerStat offers a comprehensive portfolio of products and services, including Hemostatic Device.
Non-adherent, drug-free solution for minimizing blood loss in trauma and surgical settings.
People of EmerStat
2 people are tracked at EmerStat (2 in leadership).
| Name | Role | Group |
|---|---|---|
Vishnu Sunil | Co-Founder, CEO | Leadership |
Apoorva Katragadda | Co-Founder, COO | Leadership |
Complete people profiles for EmerStat
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of EmerStat
EmerStat has 6 listed competitors in our database, 4 of them funded. They include Inari Medical, Akura Medical, Endovascular Engineering, Magneto Thrombectomy and Retriever Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inarimedical.com | 2011 | Irvine, United States | $51.89M | 696 | Catheter-based thrombectomy devices for vascular emboli removal are developed. | |
| akuramed.com | 2021 | Campbell, United States | $60M | – | Catheter-based thrombectomy devices for thrombus removal are developed. | |
| endovascularengineering.com | 2019 | Menlo Park, United States | $42M | – | Engineering services are provided to medical device manufacturers. | |
| magts.com | 2016 | Or Yehuda, Israel | – | – | Thrombectomy solutions are developed for blood clot removal in arteries. | |
| rtvmed.com | 2020 | Las Vegas, United States | – | – | Provides medical devices for vascular care and clot removal treatments. | |
| nexgenmedsystem.com | 2002 | Reno, United States | $1.02M | – | Develops thrombectomy devices for the effective removal of blood clots. |
Detailed competitors of EmerStat
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Wound Care
10 companies that operate in the same segment as EmerStat (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EmerStat
EmerStat was founded in 2022.
EmerStat is headquartered in Singapore, Singapore.
Vishnu Sunil is the current CEO of EmerStat. They have also founded this company.
EmerStat focuses on developing a first-ever non-adherent, drug-free hemostatic device that addresses bleeding management in pre-hospital and surgical environments. This superhydrophobic solution works by minimizing blood loss, accelerating clotting, and enabling easy removal to enhance overall trauma care. The company engages in research and commercialization of medical innovations, targeting healthcare professionals for improved efficiency and effectiveness, though specific locations and clients are not detailed.
EmerStat's top competitors include Inari Medical, Akura Medical and Endovascular Engineering.
EmerStat offers Hemostatic Device.